本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectar Biosciences Inc.

4.80
0.0000
成交量:9.40万
成交额:44.97万
市值:869.78万
市盈率:-0.21
高:4.91
开:4.68
低:4.65
收:4.80
数据加载中...
2021/05/10

重要事件披露

8-K - Current report
2021/05/03

重要事件披露

8-K - Current report
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/27

重要事件披露

8-K - Current report
2021/04/16

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/03/11

重要事件披露

8-K - Current report
2021/03/09

重要事件披露

8-K - Current report
2021/03/05

重要事件披露

8-K - Current report
2021/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/01/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/27

重要事件披露

8-K - Current report